Global Human Chorionic Gonadotropin Market Growth (Status and Outlook) 2025-2031

October 2025 | 80 pages | ID: G6521F011F30EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Human Chorionic Gonadotropin market size will reach US$ 3745 million by 2031.

Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.

hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.

LPI (LP Information)' newest research report, the ?Human Chorionic Gonadotropin Industry Forecast? looks at past sales and reviews total world Human Chorionic Gonadotropin sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Chorionic Gonadotropin sales for 2025 through 2031. With Human Chorionic Gonadotropin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Chorionic Gonadotropin industry.

This Insight Report provides a comprehensive analysis of the global Human Chorionic Gonadotropin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Chorionic Gonadotropin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Chorionic Gonadotropin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Chorionic Gonadotropin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Chorionic Gonadotropin.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Chorionic Gonadotropin market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Natural Source Extraction
  • Recombinant Technology
Segmentation by Application:
  • Fertility Clinics
  • Research Institutions
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Bristol Myers Squibb
  • Merck & Co
  • Ferring
  • Fresenius Kabi
  • Sun Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Chorionic Gonadotropin Market Size (2020-2031)
  2.1.2 Human Chorionic Gonadotropin Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Human Chorionic Gonadotropin by Country/Region (2020, 2024 & 2031)
2.2 Human Chorionic Gonadotropin Segment by Type
  2.2.1 Natural Source Extraction
  2.2.2 Recombinant Technology
2.3 Human Chorionic Gonadotropin Market Size by Type
  2.3.1 Human Chorionic Gonadotropin Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Human Chorionic Gonadotropin Market Size Market Share by Type (2020-2025)
2.4 Human Chorionic Gonadotropin Segment by Application
  2.4.1 Fertility Clinics
  2.4.2 Research Institutions
  2.4.3 Others
2.5 Human Chorionic Gonadotropin Market Size by Application
  2.5.1 Human Chorionic Gonadotropin Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Human Chorionic Gonadotropin Market Size Market Share by Application (2020-2025)

3 HUMAN CHORIONIC GONADOTROPIN MARKET SIZE BY PLAYER

3.1 Human Chorionic Gonadotropin Market Size Market Share by Player
  3.1.1 Global Human Chorionic Gonadotropin Revenue by Player (2020-2025)
  3.1.2 Global Human Chorionic Gonadotropin Revenue Market Share by Player (2020-2025)
3.2 Global Human Chorionic Gonadotropin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMAN CHORIONIC GONADOTROPIN BY REGION

4.1 Human Chorionic Gonadotropin Market Size by Region (2020-2025)
4.2 Global Human Chorionic Gonadotropin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Chorionic Gonadotropin Market Size Growth (2020-2025)
4.4 APAC Human Chorionic Gonadotropin Market Size Growth (2020-2025)
4.5 Europe Human Chorionic Gonadotropin Market Size Growth (2020-2025)
4.6 Middle East & Africa Human Chorionic Gonadotropin Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Human Chorionic Gonadotropin Market Size by Country (2020-2025)
5.2 Americas Human Chorionic Gonadotropin Market Size by Type (2020-2025)
5.3 Americas Human Chorionic Gonadotropin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Chorionic Gonadotropin Market Size by Region (2020-2025)
6.2 APAC Human Chorionic Gonadotropin Market Size by Type (2020-2025)
6.3 APAC Human Chorionic Gonadotropin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Human Chorionic Gonadotropin Market Size by Country (2020-2025)
7.2 Europe Human Chorionic Gonadotropin Market Size by Type (2020-2025)
7.3 Europe Human Chorionic Gonadotropin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Chorionic Gonadotropin by Region (2020-2025)
8.2 Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2020-2025)
8.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMAN CHORIONIC GONADOTROPIN MARKET FORECAST

10.1 Global Human Chorionic Gonadotropin Forecast by Region (2026-2031)
  10.1.1 Global Human Chorionic Gonadotropin Forecast by Region (2026-2031)
  10.1.2 Americas Human Chorionic Gonadotropin Forecast
  10.1.3 APAC Human Chorionic Gonadotropin Forecast
  10.1.4 Europe Human Chorionic Gonadotropin Forecast
  10.1.5 Middle East & Africa Human Chorionic Gonadotropin Forecast
10.2 Americas Human Chorionic Gonadotropin Forecast by Country (2026-2031)
  10.2.1 United States Market Human Chorionic Gonadotropin Forecast
  10.2.2 Canada Market Human Chorionic Gonadotropin Forecast
  10.2.3 Mexico Market Human Chorionic Gonadotropin Forecast
  10.2.4 Brazil Market Human Chorionic Gonadotropin Forecast
10.3 APAC Human Chorionic Gonadotropin Forecast by Region (2026-2031)
  10.3.1 China Human Chorionic Gonadotropin Market Forecast
  10.3.2 Japan Market Human Chorionic Gonadotropin Forecast
  10.3.3 Korea Market Human Chorionic Gonadotropin Forecast
  10.3.4 Southeast Asia Market Human Chorionic Gonadotropin Forecast
  10.3.5 India Market Human Chorionic Gonadotropin Forecast
  10.3.6 Australia Market Human Chorionic Gonadotropin Forecast
10.4 Europe Human Chorionic Gonadotropin Forecast by Country (2026-2031)
  10.4.1 Germany Market Human Chorionic Gonadotropin Forecast
  10.4.2 France Market Human Chorionic Gonadotropin Forecast
  10.4.3 UK Market Human Chorionic Gonadotropin Forecast
  10.4.4 Italy Market Human Chorionic Gonadotropin Forecast
  10.4.5 Russia Market Human Chorionic Gonadotropin Forecast
10.5 Middle East & Africa Human Chorionic Gonadotropin Forecast by Region (2026-2031)
  10.5.1 Egypt Market Human Chorionic Gonadotropin Forecast
  10.5.2 South Africa Market Human Chorionic Gonadotropin Forecast
  10.5.3 Israel Market Human Chorionic Gonadotropin Forecast
  10.5.4 Turkey Market Human Chorionic Gonadotropin Forecast
10.6 Global Human Chorionic Gonadotropin Forecast by Type (2026-2031)
10.7 Global Human Chorionic Gonadotropin Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Human Chorionic Gonadotropin Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bristol Myers Squibb
  11.1.1 Bristol Myers Squibb Company Information
  11.1.2 Bristol Myers Squibb Human Chorionic Gonadotropin Product Offered
  11.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bristol Myers Squibb Main Business Overview
  11.1.5 Bristol Myers Squibb Latest Developments
11.2 Merck & Co
  11.2.1 Merck & Co Company Information
  11.2.2 Merck & Co Human Chorionic Gonadotropin Product Offered
  11.2.3 Merck & Co Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Merck & Co Main Business Overview
  11.2.5 Merck & Co Latest Developments
11.3 Ferring
  11.3.1 Ferring Company Information
  11.3.2 Ferring Human Chorionic Gonadotropin Product Offered
  11.3.3 Ferring Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Ferring Main Business Overview
  11.3.5 Ferring Latest Developments
11.4 Fresenius Kabi
  11.4.1 Fresenius Kabi Company Information
  11.4.2 Fresenius Kabi Human Chorionic Gonadotropin Product Offered
  11.4.3 Fresenius Kabi Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Fresenius Kabi Main Business Overview
  11.4.5 Fresenius Kabi Latest Developments
11.5 Sun Pharmaceutical
  11.5.1 Sun Pharmaceutical Company Information
  11.5.2 Sun Pharmaceutical Human Chorionic Gonadotropin Product Offered
  11.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sun Pharmaceutical Main Business Overview
  11.5.5 Sun Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Human Chorionic Gonadotropin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Human Chorionic Gonadotropin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Natural Source Extraction
Table 4. Major Players of Recombinant Technology
Table 5. Human Chorionic Gonadotropin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Human Chorionic Gonadotropin Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Human Chorionic Gonadotropin Market Size Market Share by Type (2020-2025)
Table 8. Human Chorionic Gonadotropin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Human Chorionic Gonadotropin Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Human Chorionic Gonadotropin Market Size Market Share by Application (2020-2025)
Table 11. Global Human Chorionic Gonadotropin Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Human Chorionic Gonadotropin Revenue Market Share by Player (2020-2025)
Table 13. Human Chorionic Gonadotropin Key Players Head office and Products Offered
Table 14. Human Chorionic Gonadotropin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human Chorionic Gonadotropin Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Human Chorionic Gonadotropin Market Size Market Share by Region (2020-2025)
Table 19. Global Human Chorionic Gonadotropin Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Human Chorionic Gonadotropin Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Human Chorionic Gonadotropin Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Human Chorionic Gonadotropin Market Size Market Share by Country (2020-2025)
Table 23. Americas Human Chorionic Gonadotropin Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Human Chorionic Gonadotropin Market Size Market Share by Type (2020-2025)
Table 25. Americas Human Chorionic Gonadotropin Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Human Chorionic Gonadotropin Market Size Market Share by Application (2020-2025)
Table 27. APAC Human Chorionic Gonadotropin Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Human Chorionic Gonadotropin Market Size Market Share by Region (2020-2025)
Table 29. APAC Human Chorionic Gonadotropin Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Human Chorionic Gonadotropin Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Human Chorionic Gonadotropin Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Human Chorionic Gonadotropin Market Size Market Share by Country (2020-2025)
Table 33. Europe Human Chorionic Gonadotropin Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Human Chorionic Gonadotropin Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Human Chorionic Gonadotropin Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Human Chorionic Gonadotropin
Table 39. Key Market Challenges & Risks of Human Chorionic Gonadotropin
Table 40. Key Industry Trends of Human Chorionic Gonadotropin
Table 41. Global Human Chorionic Gonadotropin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Human Chorionic Gonadotropin Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Human Chorionic Gonadotropin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Human Chorionic Gonadotropin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bristol Myers Squibb Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 46. Bristol Myers Squibb Human Chorionic Gonadotropin Product Offered
Table 47. Bristol Myers Squibb Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bristol Myers Squibb Main Business
Table 49. Bristol Myers Squibb Latest Developments
Table 50. Merck & Co Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 51. Merck & Co Human Chorionic Gonadotropin Product Offered
Table 52. Merck & Co Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck & Co Main Business
Table 54. Merck & Co Latest Developments
Table 55. Ferring Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 56. Ferring Human Chorionic Gonadotropin Product Offered
Table 57. Ferring Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Ferring Main Business
Table 59. Ferring Latest Developments
Table 60. Fresenius Kabi Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 61. Fresenius Kabi Human Chorionic Gonadotropin Product Offered
Table 62. Fresenius Kabi Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Fresenius Kabi Main Business
Table 64. Fresenius Kabi Latest Developments
Table 65. Sun Pharmaceutical Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 66. Sun Pharmaceutical Human Chorionic Gonadotropin Product Offered
Table 67. Sun Pharmaceutical Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sun Pharmaceutical Main Business
Table 69. Sun Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Human Chorionic Gonadotropin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Chorionic Gonadotropin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Human Chorionic Gonadotropin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Human Chorionic Gonadotropin Sales Market Share by Country/Region (2024)
Figure 8. Human Chorionic Gonadotropin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Human Chorionic Gonadotropin Market Size Market Share by Type in 2024
Figure 10. Human Chorionic Gonadotropin in Fertility Clinics
Figure 11. Global Human Chorionic Gonadotropin Market: Fertility Clinics (2020-2025) & ($ millions)
Figure 12. Human Chorionic Gonadotropin in Research Institutions
Figure 13. Global Human Chorionic Gonadotropin Market: Research Institutions (2020-2025) & ($ millions)
Figure 14. Human Chorionic Gonadotropin in Others
Figure 15. Global Human Chorionic Gonadotropin Market: Others (2020-2025) & ($ millions)
Figure 16. Global Human Chorionic Gonadotropin Market Size Market Share by Application in 2024
Figure 17. Global Human Chorionic Gonadotropin Revenue Market Share by Player in 2024
Figure 18. Global Human Chorionic Gonadotropin Market Size Market Share by Region (2020-2025)
Figure 19. Americas Human Chorionic Gonadotropin Market Size 2020-2025 ($ millions)
Figure 20. APAC Human Chorionic Gonadotropin Market Size 2020-2025 ($ millions)
Figure 21. Europe Human Chorionic Gonadotropin Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Human Chorionic Gonadotropin Market Size 2020-2025 ($ millions)
Figure 23. Americas Human Chorionic Gonadotropin Value Market Share by Country in 2024
Figure 24. United States Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Human Chorionic Gonadotropin Market Size Market Share by Region in 2024
Figure 29. APAC Human Chorionic Gonadotropin Market Size Market Share by Type (2020-2025)
Figure 30. APAC Human Chorionic Gonadotropin Market Size Market Share by Application (2020-2025)
Figure 31. China Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 35. India Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Human Chorionic Gonadotropin Market Size Market Share by Country in 2024
Figure 38. Europe Human Chorionic Gonadotropin Market Size Market Share by Type (2020-2025)
Figure 39. Europe Human Chorionic Gonadotropin Market Size Market Share by Application (2020-2025)
Figure 40. Germany Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 41. France Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Human Chorionic Gonadotropin Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 54. APAC Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 55. Europe Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 57. United States Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 58. Canada Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 59. Mexico Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 60. Brazil Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 61. China Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 62. Japan Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 63. Korea Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 65. India Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 66. Australia Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 67. Germany Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 68. France Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 69. UK Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 70. Italy Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 71. Russia Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 72. Egypt Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 73. South Africa Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 74. Israel Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 75. Turkey Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)
Figure 76. Global Human Chorionic Gonadotropin Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Human Chorionic Gonadotropin Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Human Chorionic Gonadotropin Market Size 2026-2031 ($ millions)